Androgen receptor inhibitor treatments: Cardiovascular adverse events and comorbidity considerations in patients with non-metastatic prostate cancer.

CONCLUSION: Management strategies for patients with mCRPC also treated for comorbidities including CV disease require appropriate selection of therapy, diet, and exercise to meet the needs of the individual patient profile.
PMID: 32958445 [PubMed - as supplied by publisher]

Source: Urologic Oncology - September 17, 2020 Category: Urology & Nephrology Authors: Morgans AK, Shore N, Cope D, McNatty A, Moslehi J, Gomella L, Sartor O Tags: Urol Oncol Source Type: research